Dental Recycling North America, Inc. v. Stoma Ventures, Inc.

Background

Dental Recycling North America, Inc. ("DRNA") sued Stoma Ventures, LLC, alleging false advertising under the federal Lanham Act and unfair competition and false advertising under Missouri common law. DRNA alleged that Stoma falsely advertised Capt-all as an amalgam separator and falsely claimed compliance with Environmental Protection Agency regulations. DRNA sought an injunction against further advertising, promotion, manufacture, importation, offering for sale, or sale of Capt-all unless the product was found to comply with those regulations.

Stoma moved to dismiss under Federal Rule of Civil Procedure 12(b)(2) for lack of personal jurisdiction. In the alternative, Stoma moved to transfer the case to the United States District Court for the Eastern District of Missouri under 28 U.S.C. § 1406(a). DRNA asked for permission to conduct discovery limited to whether Stoma had sufficient connections with New York.

Personal Jurisdiction

The court explained that general jurisdiction allows a defendant to be sued on all claims, while specific jurisdiction applies to claims connected to the defendant’s conduct in the forum. DRNA alleged general jurisdiction under New York Civil Practice Law and Rules § 301, but it did not meaningfully respond to Stoma’s arguments against general jurisdiction. The court therefore treated DRNA’s general-jurisdiction argument as abandoned. The court also stated that, even without abandonment, the allegations would not establish general jurisdiction under the constitutional standard for when a company is essentially at home in a state.

DRNA also relied on specific jurisdiction under New York Civil Practice Law and Rules § 302(a)(1) and (a)(3). It alleged that Stoma had contracts with Henry Schein, Inc. and Darby Dental Supply, LLC, distributors headquartered in New York, and that those arrangements allowed Stoma products to reach New York customers. DRNA further alleged that the distributors listed Capt-all on their websites and that Stoma derived substantial revenue from New York sales.

Stoma responded that it did not fulfill Capt-all orders placed through its own website from New York, was unaware of Capt-all sales by the distributors in New York, and lacked contractual or practical control over where the distributors resold the products. The court concluded that the existing materials did not establish that Capt-all had been sold in New York, but also did not conclusively rule out such sales. In particular, the court found that Stoma’s submissions did not specifically state that Capt-all had not been sold to New York customers or that Stoma had instructed the distributors not to sell there.

Ruling on Discovery and Motions

The court found a genuine issue of jurisdictional fact and held that limited jurisdictional discovery was warranted. The permitted discovery was limited to written requests and documents concerning: whether Stoma permitted or intended Henry Schein or Darby Dental to sell Capt-all in New York; whether Capt-all was sold to New York customers from January 2020 through the filing of the lawsuit; and what percentage of Stoma’s total revenue came from those sales. The court did not authorize discovery into the merits of DRNA’s false-advertising claims.

The court granted DRNA leave to conduct the limited jurisdictional discovery, stayed Stoma’s motion to dismiss and alternative motion to transfer pending that discovery, and stayed the case pending further order. It directed DRNA and Stoma to submit supplemental letter briefs addressing what the discovery showed about personal jurisdiction. The opinion did not decide whether personal jurisdiction exists, whether the case should be transferred, or whether DRNA’s underlying claims have merit.